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Meir Wetzler, MD
Razelle Kurzrock, MD1; Zeev Estrov, MD2; Moshe Talpaz, MD3; and Hagop M. Kantarjian, MD2
Meir Wetzler, MD, died on February 23, 2015 at the age of 60 years after sustaining ski injuries in Colorado on February
7, 2015. Many of us realize that the world has lost a special person who was a devoted physician, a leader in the leukemia
field, and a wonderful colleague.
Dr.Wetzler was professor of medicine and chief of the Leukemia Section at Roswell Park Cancer Institute in Buffalo,
New York. Dr. Wetzler moved to Roswell Park in the 1990s and rose through the ranks. He was a highly committed and
compassionate physician who helped set the standards for leukemia care. He published over 200 articles in his field, with a
focus on cytokines, immunotherapy, and the BCR gene in leukemia.
Dr. Wetzler was also an accomplished athlete, and was skilled at snowboarding, skiing, and running. He participated
in Ironman triathlons, and was considered more fit than many half his age.
Born in Israel, Dr. Wetzler earned his medical degree from The Hebrew University Hadassah Medical School in Je-
rusalem and completed his internal medicine training at the Kaplan Medical Center in Rehovot. He completed training
in medical oncology with an emphasis on biological therapy at The University of Texas MD Anderson Cancer Center in
Houston.
Razelle Kurzrock, MD, now Senior Deputy Center Director at the University of California at San Diego Moores
Cancer Center, remembers him well from his time atMDAnderson Cancer Center. “He was a very dedicated investigator.
While he was with us, he published several very important papers, including a study in PNAS [Proceedings of the National
Figure 1. Dr. Meir Wetzler. Photo Courtesy of Roswell Park Cancer Institute.
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Academy of Sciences of the United States of America], one of
the foremost journals, on the role of the BCR gene in
chronic myelogenous leukemia. He also described, for the
first time, a new disease entity, which we called WHIM
syndrome. By 2014, the genetics of WHIM was known,
and we circled back and wrote another paper on it, tying
the story of this rare disorder together, 24 years after its
initial publication.” However, Dr. Kurzrock notes that
what she remembers best about Dr. Wetzler was his seri-
ousness and his dedication–and that he had a distinctive
voice. “Even years after he left MD Anderson, whenever
we met at a conference, I was immediately struck by his
unique voice. I believe that his voice will be sorely missed
by many of us.”
Moshe Talpaz, MD, who is also a prominent leuke-
mia researcher, knew Dr. Wetzler well. “It saddened me
very much to learn of the tragic news,” he says. “I recruited
Dr. Wetzler to MD Anderson Cancer Center and was im-
mediately impressed with his total commitment to his
work and his ability to devote very long hours to research.
While working together at MD Anderson, Meir studied
and published on the effect of bone marrow stromal cyto-
kines in chronic myelogenous leukemia (CML), and the
molecular biology of CML. He was a prolific writer and
published extensively. I was not surprised to see him
become a successful investigator at Roswell Park. Dr. Wet-
zler and I maintained communications over the years, and
his passing at the peak of his productivity has been painful
to all those who knew him, including his patients.”
Zeev Estrov, MD, a professor and well-known
researcher in the Department of Leukemia at The Univer-
sity of Texas MD Anderson Cancer Center, is a long-term
colleague and friend of Dr. Wetzler. He stated the follow-
ing: “It still hurts and is hard to overcome. I met him at
ASH [American Society of Hematology] in December,
and he looked like a man in his late 30s. I knew him well
from the Kaplan Hospital in Israel, as an intern and resi-
dent in the Department of Medicine C. He was an out-
standing, dedicated physician who cared deeply about his
patients, and did all he could to provide them with the
best possible care. His parents, whom I met, were Holo-
caust survivors, and he was their only child.”
Dr. Wetzler is survived by his wife Chana and 4
children: Mor, Shira, Adam, andModi.
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